A new spinal cord implant may help people with spinal muscular atrophy (SMA) regain some muscle function, giving the ...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

How a tiny spinal implant could help those with muscle-wasting disease - Three people with a muscle-destroying disease got ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

"Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease.

In surveys, parents of children with SMA and healthcare professionals in Sweden note the many ways the pandemic affected ...

Back to Healio Topline results from a phase 3 clinical trial showed an investigational gene therapy for young people with spinal muscular atrophy type 2 increased mobility and slowed disease ...

Novartis has shared positive top-line results from a late-stage study of its investigational gene therapy in patients aged two to less than 18 years with the rare neuromuscular disease spinal muscular ...